Young Breast Cancer Cohort Study

• Conditions: Breast Cancer

• Registration Number: NCT03131089
• Lead Sponsor: Samsung Medical Center

Brief Summary

This study is prospective cohort study to investigate and identify comprehensively the clinicopathological features and long-term outcome of young breast cancer (YBC).

We have enrolled Breast cancer patients under 40 year-old and collected their baseline characteristics including tumor character, familiar history and other background information. Moreover, we have collected breast cancer tissue/blood sample for analyzing genetic characteristics, if patient agree to genetic analysis.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2013-04-11
• Status Verified: 2017-04
• Study First Submitted: 2017-04-16
• Study First Submitted QC: 2017-04-26
• Last Update Submitted: 2017-04-26
• Study First Posted: 2017-04-27
• Last Update Posted: 2017-04-27
• Primary Completion: 2018-02-17
• Study Completion: 2023-04-10

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 2000

Inclusion Criteria

1. Diagnosis with breast cancer
2. Age under 40 year-old or diagnosis with breast cancer at pregnancy or within 1year after delivery
3. Obtained informed consent form

Read More

Exclusion Criteria

1. Cannot understand or disagree to informed consent form

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Progression free survival	From date of surgery until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 60 months	Time to detect disease recurrence from surgery date

Trial Locations

Locations (1)

Samsung Medical Center; 🇰🇷 Seoul, Korea, Republic of